MedTrace Logo

It's Your Game: An Innovative Approach to Preventing Teen Dating Violence

NCT03482687 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 834

Last updated 2018-03-29

No results posted yet for this study

Summary

The purpose of this study is to evaluate Me \& You: Building Healthy Relationships, a classroom- and computer-based healthy relationships and dating violence prevention curriculum for 6th grade students, in a large, urban public school district in Southeast Texas.

Conditions

  • Adolescent Behavior
  • Interpersonal Relationships
  • Domestic Violence
  • Physical Violence

Interventions

BEHAVIORAL

Me & You: Building Healthy Relationships

Me \& You: Building Healthy Relationships is a classroom- and computer-based healthy relationships curriculum for middle school students. It consists of thirteen 25-minute lessons: 5 classroom, 5 computer-only, and 3 classroom-computer hybrid. The curriculum integrates group-based classroom activities (e.g., role-plays, group discussion, and other skill-building activities) and computer-based activities, some of which are individually tailored. The curriculum was adapted from an existing effective sex education and relationship curriculum, It's Your Game…Keep it Real (IYG), which was enhanced to more explicitly address teen dating violence (TDV).

Sponsors & Collaborators

  • The University of Texas Health Science Center, Houston

    lead OTHER

Principal Investigators

  • Melissa Peskin, PhD · University of Texas Houston School of Public Health

  • Susan Tortolero Emery, PhD · University of Texas Houston School of Public Health

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
11 Years
Max Age
14 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-09-30
Primary Completion
2015-05-31
Completion
2015-05-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03482687 on ClinicalTrials.gov